Verve Therapeutics
VERV
$6.16
Share price
-0.96%
Change (1 day)
-61.04%
Change (1 year)
Verve Therapeutics (VERV) - Cash on Hand
Cash on Hand as of December 2023 : $0.62 B
According to Verve Therapeutics's latest financial reports the company has $0.62 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Verve Therapeutics - Cash on Hand chart (from 2020 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.62 B | 12.46% |
| 2022-12-31 | $0.55 B | 53.92% |
| 2021-12-31 | $0.36 B | 399.84% |
| 2020-12-31 | $72.11 M | 283.94% |
| 2019-12-31 | $18.78 M |